Independent
Tenure on this board
5.6 yrs
Also a director at
Denali Therapeutics Inc (DNLI)Bridgebio Pharma Inc (BBIO)
Meeting calendar
JAZZ · Annual meeting · Thursday, July 24, 2025
Jazz Pharmaceuticals PLC
4 nominees · 4 ballot items.
The 2025 Jazz AGM includes four management proposals: election of four director nominees, advisory ratification of the KPMG auditor and its remuneration, non-binding advisory vote on executive compensation, and renewal of the authority to issue ordinary shares for cash without pre-emption rights.
Market cap
$14.9B
1Y TSR
+112.8%
Board grade
B-
Record date
May 29, 2025
Filing
DEF 14A
Meeting concluded · Jul 24, 2025
Follow how the vote landed and what changed on Jazz Pharmaceuticals PLC’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
Proposals
On the ballot4
- 1
Election of Directors
ManagementBoard: FORTo elect by separate resolutions each of the four nominees for director named in our accompanying proxy statement to hold office until the 2028 AGM.
- 2
Ratify the Appointment and Approve Remuneration of the Auditor
ManagementBoard: FORTo ratify, on a non-binding advisory basis, the appointment of KPMG as our independent auditors for the fiscal year ending December 31, 2025 and to authorize, in a binding vote, our board of directors, acting through our audit committee, to determine the independent auditors’ remuneration.
- 3
Non-Binding Advisory Vote on Executive Compensation
ManagementBoard: FORTo approve, on a non-binding advisory basis, the compensation of our named executive officers, as disclosed in our proxy statement.
- 4
Board Authority to Allot and Issue Ordinary Shares for Cash Without First Offering Shares to Existing Shareholders
ManagementBoard: FORTo grant our board of directors authority under Irish law to allot and issue ordinary shares for cash without first offering those ordinary shares to existing shareholders pursuant to the statutory pre-emption right.
Director elections
Nominees on the ballot4
Independent
Tenure on this board
17.0 yrs
Also a director at
Vera Therapeutics Inc (VERA)Zenas Biopharma Inc (ZBIO)Bioage Labs Inc (BIOA)Veradermics Inc (MANE)
Not independent
Tenure on this board
14.5 yrs
Independent
Tenure on this board
13.2 yrs
Also a director at
Eton Pharmaceuticals Inc (ETON)
Ownership
Latest 13F quarterTop institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | 5.4% | 3,373,268 | $638M |
| 2 | VANGUARD PORTFOLIO MANAGEMENT LLC | 4.8% | 2,983,242 | $564M |
| 3 | Capital World Investors | 4.3% | 2,673,376 | $505M |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 4.2% | 2,648,333 | $501M |
| 5 | LSV ASSET MANAGEMENT | 3.8% | 2,386,840 | $451M |
| 6 | FRANKLIN RESOURCES INC | 3.1% | 1,915,157 | $362M |
| 7 | STATE STREET CORP | 3.0% | 1,891,646 | $358M |
| 8 | FMR LLC | 2.9% | 1,789,410 | $338M |
| 9 | DIMENSIONAL FUND ADVISORS LP | 2.8% | 1,781,573 | $337M |
| 10 | BlackRock, Inc. | 2.8% | 1,746,867 | $330M |
Peers
Nearest market capOther Healthcare sector meetings6
Upcoming shareholder meetings at Jazz Pharmaceuticals PLC’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Steris PLCSTE
Annual meeting·Jul 31, 2026·$20.6B
Amneal Pharmaceuticals IncAMRX
Special meeting·Jul 31, 2026·$5.5B
Catalyst Pharmaceuticals IncCPRX
Special meeting·Jul 8, 2026·$3.8B
Organon & CoOGN
Special meeting·Jul 23, 2026·$3.6B
Haemonetics CorpHAE
Annual meeting·Jul 24, 2026·$3.4B
Prestige Consumer Healthcare IncPBH
Annual meeting·Aug 4, 2026·$2.2B
Reference
Frequently asked questions
- When is the Jazz Pharmaceuticals PLC 2025 annual meeting?
- Jazz Pharmaceuticals PLC (JAZZ) holds its 2025 annual shareholder meeting on Thursday, July 24, 2025.
- What is the record date for the Jazz Pharmaceuticals PLC 2025 meeting?
- The record date for the Jazz Pharmaceuticals PLC 2025 meeting is Thursday, May 29, 2025. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Jazz Pharmaceuticals PLC's 2025 meeting?
- The board is presenting 4 director nominees at the Jazz Pharmaceuticals PLC 2025 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Jazz Pharmaceuticals PLC 2025 meeting?
- Shareholders will vote on 4 proposals at the Jazz Pharmaceuticals PLC 2025 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.